Iperton

Enalapril maleate, the active ingredient in Iperton, is an ACE inhibitor presented as an oral tablet for oral use. It is combined with hydrochlorothiazide, a thiazide diuretic, to treat hypertension and related cardiovascular conditions in adults. The combination works by lowering blood pressure through vasodilation and reduction of fluid volume, providing a dual mechanism for effective control of elevated blood pressure.

GNH USA supplies Iperton as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and regulatory requirements to ensure product integrity across global markets.

Iperton is used to manage high blood pressure and related cardiovascular disorders by targeting the renin‑angiotensin system and promoting diuresis. - Hypertension: lowers systolic and diastolic pressure in patients with primary hypertension. - Essential hypertension: provides sustained blood pressure control when lifestyle measures are insufficient. - Heart failure (adjunct therapy): assists in reducing preload and afterload, supporting standard heart‑failure regimens.

Iperton may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Cough: dry, persistent throat irritation. - Dizziness or light‑headedness, especially when standing. - Headache. - Fatigue or weakness. - Increased urination or electrolyte disturbances (e.g., low potassium). - Mild gastrointestinal upset such as nausea.

Serious or Rare Side Effects: - Angioedema: swelling of face, lips, tongue, or throat. - Severe hypotension: markedly low blood pressure. - Acute kidney injury or worsening renal function. - Hyperkalemia: elevated blood potassium levels. - Severe electrolyte imbalance (e.g., hyponatremia).

Before initiating Iperton, consider patient‑specific factors and monitor appropriately. - Renal function: assess baseline creatinine and eGFR, adjust if impaired. - Electrolytes: monitor potassium and sodium levels regularly. - Pregnancy: contraindicated in the second and third trimesters (Category D). - Concomitant potassium‑sparing agents: avoid to reduce hyperkalemia risk. - History of angioedema: discontinue if swelling occurs. - Store at room temperature: keep below 25 °C, retain in original packaging, protect from moisture.

Iperton interacts with several medicines that can amplify or diminish its antihypertensive effect.

Major Interactions (Avoid): - Angiotensin II receptor blockers (ARBs): combined use may cause excessive hypotension and renal dysfunction. - Potassium‑sparing diuretics or supplements: risk of dangerous hyperkalemia. - Lithium: enalapril can increase lithium concentrations, leading to toxicity. - NSAIDs (e.g., ibuprofen, naproxen): may reduce antihypertensive efficacy and impair renal function.

Moderate Interactions (Monitor Closely): - Beta‑blockers: additive blood‑pressure lowering effect. - Antidiabetic agents: thiazide component may raise blood glucose. - CYP450 inhibitors (e.g., ritonavir): may increase enalapril levels. - Diuretics (other than thiazides): monitor electrolyte balance. - Antacids containing aluminum or magnesium: may affect absorption of enalapril.